Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma

por Sanchez, Larysa, Wang, Yucai, Siegel, David S., Wang, Michael L.
Publicado 2016

Elotuzumab for the treatment of multiple myeloma

por Wang, Yucai, Sanchez, Larysa, Siegel, David S., Wang, Michael L.
Publicado 2016

B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies

por Sanchez, Larysa, Dardac, Alexandra, Madduri, Deepu, Richard, Shambavi, Richter, Joshua
Publicado 2021

1741. Invasive Fungal Infections in Patients with Multiple Myeloma in the Era of Novel Therapies

por Baneman, Emily, Chari, Ajai, Rana, Meenakshi, Dunn, Dallas, Sullivan, Timothy, Taimur, Sarah, Sanchez, Larysa, Jacobs, Samantha E
Publicado 2019

Gastric adenocarcinoma: clinicopathologic differences among Hispanics and non-Hispanic whites. A single Institution’s experience over 14 years

por Duma, Narjust, Sanchez, Larysa J., Castro, Yulanka S., Jennis, Andrew A., McCain, Donald A., Gutierrez, Martin E., Bamboat, Zubin M.
Publicado 2016

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma

por Sanchez, Larysa, Richter, Joshua, Cho, Hearn Jay, Jagannath, Sundar, Madduri, Deepu, Parekh, Samir, Richard, Shambavi, Tam, Lowena, Verina, Daniel, Chari, Ajai
Publicado 2021

Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis

por Rosenbaum, Cara A., Özbek, Umut, Sanchez, Larysa, Lagdameo, Jonathan, Abrahams, Alex, Hassoun, Hani, Lahoud, Oscar, Niesvizky, Ruben, Landau, Heather J., Osman, Keren
Publicado 2022

Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach

por Laganà, Alessandro, Beno, Itai, Melnekoff, David, Leshchenko, Violetta, Madduri, Deepu, Ramdas, Dennis, Sanchez, Larysa, Niglio, Scot, Perumal, Deepak, Kidd, Brian A., Miotto, Riccardo, Houldsworth, Jane, Shaknovich, Rita, Chari, Ajai, Cho, Hearn Jay, Barlogie, Bart, Jagannath, Sundar, Dudley, Joel T., Parekh, Samir
Publicado 2018

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

por Mouhieddine, Tarek H., Van Oekelen, Oliver, Melnekoff, David T., Li, Jeanne, Ghodke-Puranik, Yogita, Lancman, Guido, Thibaud, Santiago, Pan, Darren, Rajeeve, Sridevi, Agte, Sarita, Aleman, Adolfo, Sanchez, Larysa, Richard, Shambavi, Rossi, Adriana, Richter, Joshua, Cho, Hearn Jay, Rodriguez, Cesar, Lagana, Alessandro, Moshier, Erin, Chari, Ajai, Jagannath, Sundar, Parekh, Samir
Publicado 2022